Works matching IS 14642662 AND DT 2012 AND VI 13 AND IP 8

Results: 6
    1
    2
    3
    4
    5

    Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study

    Published in:
    HIV Medicine, 2012, v. 13, n. 8, p. 488, doi. 10.1111/j.1468-1293.2012.01000.x
    By:
    • Olmo, M;
    • Saumoy, M;
    • Alonso-Villaverde, C;
    • Peñaranda, M;
    • Gutiérrez, F;
    • Romeu, J;
    • Larrousse, M;
    • Curto, J;
    • Domingo, P;
    • Oteo, JA;
    • Vila, A;
    • Podzamczer, D
    Publication type:
    Article
    6

    Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy

    Published in:
    HIV Medicine, 2012, v. 13, n. 8, p. 505, doi. 10.1111/j.1468-1293.2012.01004.x
    By:
    • Valantin, MA;
    • Kolta, S;
    • Flandre, P;
    • Algarte Genin, M;
    • Meynard, JL;
    • Ponscarme, D;
    • Slama, L;
    • Cuzin, L;
    • Kerviler, E;
    • Inaoui, R;
    • Katlama, C
    Publication type:
    Article